Announcement
25 Jul 2020
On 25 July 2020, Biomedical Advanced Research and Development Authority (BARDA) announced expanding its existing partnership with Moderna, Inc to support the Phase 3 clinical trial of Moderna’s COVID-19 vaccine candidate.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
25 Jul 2020
Revocation date:
No revocation date
Updated: 25 Jul 2020
State aid, unspecified
In force
On 25 July 2020, Biomedical Advanced Research and Development Authority (BARDA) announced expanding its existing partnership with Moderna, Inc to support the Phase 3 clinical trial of Moderna’s mRN...
Sign in to see more
Related State Acts
15 Jun 2021
United States of America: Moderna is awarded $144.1 million in support of the COVID-19 vaccine development for pediatric population, aged between six months to 12 years old
18 Apr 2021
United States of America: Moderna is awarded $236.4 million in support of the additional development of mRNA-1273 vaccine
12 Mar 2021
United States of America: Moderna is awarded $62.7 million in support of the COVID-19 vaccine additional development
11 Feb 2021
United States of America: U.S. Government purchases addition COVID-19 vaccine doses from Moderna for $1.750 billion
11 Dec 2020
United States of America: Moderna is awarded a $1.66 billion contract for the manufacture and delivery of additional COVID-19 vaccines doses
24 May 2020
United States of America: Moderna is awarded $53 million in support of the COVID-19 vaccine manufacturing capacity expansion
16 Apr 2020
United States of America: Moderna is awarded $430 million for the COVID-19 vaccine development process
Threads
See all
This state act is not part of any Thread yet.